The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Assessment of tumor hypoxia in BEV resistant GBM using FMISO 18F-PET and MRI.
 
Yichu Liu
No Relationships to Disclose
 
Eudocia Quant Lee
Consulting or Advisory Role - Genentech/Roche
 
Shiliang Huang
No Relationships to Disclose
 
Mark Muzi
No Relationships to Disclose
 
David A. Reardon
Honoraria - Abbvie; Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Cavion; Celldex; Genentech/Roche; Inovio Pharmaceuticals; Juno Therapeutics; Merck; Midatech Pharma; Momenta Pharmaceuticals; Monteris Medical; Novartis; Novocure; Oxigene; Regeneron; Stemline Therapeutics
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Midatech Pharma (Inst); Tragara (Inst)
 
Patrick Y. Wen
No Relationships to Disclose
 
Andrew Jacob Brenner
Honoraria - Vascular Biogenics
Consulting or Advisory Role - NanoTX; Vascular Biogenics
Research Funding - miRNA Therapeutics (Inst); Threshold Pharmaceuticals; Vascular Biogenics
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics